Bioinvent International Ab News - 0H22

Resolutions at BioInvent's Annual General Meeting 2021

Resolutions at BioInvent's Annual General Meeting 2021 PR Newswire LUND, Sweden, April 29, 2021 LUND, Sweden, April 29, 2021 /PRNewswire/ -- The...

Resolutions at BioInvent's Annual General Meeting 2021

Resolutions at BioInvent's Annual General Meeting 2021 PR Newswire LUND, Sweden, April 29, 2021 LUND, Sweden, April 29, 2021 /PRNewswire/ -- The...

BioInvent's partner Oncurious NV presents Phase I data on TB-403 in pediatric cancer

BioInvent's partner Oncurious NV presents Phase I data on TB-403 in pediatric cancer PR Newswire LUND, Sweden, April 12, 2021 LUND, Sweden, April...

BioInvent's partner Oncurious NV presents Phase I data on TB-403 in pediatric cancer

BioInvent's partner Oncurious NV presents Phase I data on TB-403 in pediatric cancer PR Newswire LUND, Sweden, April 12, 2021 LUND, Sweden, April...

BioInvent International's Annual Report 2020 published

BioInvent International's Annual Report 2020 published PR Newswire LUND, Sweden, April 8, 2021 LUND, Sweden, April 8, 2021 /PRNewswire/...

BioInvent International's Annual Report 2020 published

BioInvent International's Annual Report 2020 published PR Newswire LUND, Sweden, April 8, 2021 LUND, Sweden, April 8, 2021 /PRNewswire/...

Change in the number of shares and votes in BioInvent International AB

Change in the number of shares and votes in BioInvent International AB PR Newswire LUND, Sweden, March 31, 2021 LUND, Sweden, March 31, 2021...

Change in the number of shares and votes in BioInvent International AB

Change in the number of shares and votes in BioInvent International AB PR Newswire LUND, Sweden, March 31, 2021 LUND, Sweden, March 31, 2021...

BioInvent International Financial Statement January 1 - December 31, 2020

BioInvent International Financial Statement January 1 - December 31, 2020 Promising early interim efficacy data on our lead drug candidate PR...

BioInvent International Financial Statement January 1 - December 31, 2020

BioInvent International Financial Statement January 1 - December 31, 2020 Promising early interim efficacy data on our lead drug candidate PR...

Nomination Committee appointed for BioInvent International's Annual General Meeting 2021

Nomination Committee appointed for BioInvent International's Annual General Meeting 2021 PR Newswire LUND, Sweden, Dec. 9, 2020 LUND, Sweden...

Nomination Committee appointed for BioInvent International's Annual General Meeting 2021

Nomination Committee appointed for BioInvent International's Annual General Meeting 2021 PR Newswire LUND, Sweden, Dec. 9, 2020 LUND, Sweden...

Record date for reverse share split in BioInvent International determined

Record date for reverse share split in BioInvent International determined PR Newswire LUND, Sweden, Dec. 7, 2020 LUND, Sweden , Dec. 7, 2020...

Record date for reverse share split in BioInvent International determined

Record date for reverse share split in BioInvent International determined PR Newswire LUND, Sweden, Dec. 7, 2020 LUND, Sweden , Dec. 7, 2020...

Resolutions at the Extraordinary General Meeting in BioInvent on November 27, 2020

Resolutions at the Extraordinary General Meeting in BioInvent on November 27, 2020 PR Newswire LUND, Sweden, Nov. 27, 2020 LUND, Sweden, Nov. 27...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Bioinvent International Ab (0H22)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

0H22 News

Resolutions at BioInvent's Annual General Meeting 2021

Resolutions at BioInvent's Annual General Meeting 2021

BioInvent's partner Oncurious NV presents Phase I data on TB-403 in pediatric cancer

BioInvent's partner Oncurious NV presents Phase I data on TB-403 in pediatric cancer

BioInvent International's Annual Report 2020 published

BioInvent International's Annual Report 2020 published

Change in the number of shares and votes in BioInvent International AB

Change in the number of shares and votes in BioInvent International AB

BioInvent International Financial Statement January 1 - December 31, 2020

BioInvent International Financial Statement January 1 - December 31, 2020

Nomination Committee appointed for BioInvent International's Annual General Meeting 2021

Nomination Committee appointed for BioInvent International's Annual General Meeting 2021

Record date for reverse share split in BioInvent International determined

Record date for reverse share split in BioInvent International determined

Resolutions at the Extraordinary General Meeting in BioInvent on November 27, 2020

0H22 Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

Bioinvent International Ab (0H22) News

Bioinvent International Ab (0H22)

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

0H22 News

Resolutions at BioInvent's Annual General Meeting 2021

Resolutions at BioInvent's Annual General Meeting 2021

BioInvent's partner Oncurious NV presents Phase I data on TB-403 in pediatric cancer

BioInvent's partner Oncurious NV presents Phase I data on TB-403 in pediatric cancer

BioInvent International's Annual Report 2020 published

BioInvent International's Annual Report 2020 published

Change in the number of shares and votes in BioInvent International AB

Change in the number of shares and votes in BioInvent International AB

BioInvent International Financial Statement January 1 - December 31, 2020

BioInvent International Financial Statement January 1 - December 31, 2020

Nomination Committee appointed for BioInvent International's Annual General Meeting 2021

Nomination Committee appointed for BioInvent International's Annual General Meeting 2021

Record date for reverse share split in BioInvent International determined

Record date for reverse share split in BioInvent International determined

Resolutions at the Extraordinary General Meeting in BioInvent on November 27, 2020

0H22 Discussion

Your Recent History